Introduction L'apremilast complète l'arsenal thérapeutique du psoriasis depuis octobre
2016. Les données des études cliniques sont rassurantes en termes de tolérance mais on …

Background Little has been published on the real‐world effectiveness and safety of
apremilast in psoriasis. Objectives To evaluate the effectiveness, safety and drug survival of …

Apremilast has been approved as an effective and safe treatment for psoriasis, but clinical
trial results may differ from real‐life data. This retrospective cross‐sectional study evaluated …

Introduction Real-world data on the needs of patients with psoriasis and patient-perceived
benefits of apremilast are limited. We report such data from France. Methods The …

Objectives The aim of this paper is to present our personal as well as literature-sourced real-
world evidenced on apremilast use in psoriasis patients with serious baseline comorbidities …

Introduction Apremilast is approved for the treatment of psoriasis and psoriatic arthritis.
However, data on the efficacy and safety of apremilast in clinical practice are limited. We …

Background Experience in the use of apremilast in clinical practice complements the
information available from pivotal clinical trials. Materials and methods Following a review of …

The introduction of several new therapeutic agents, predominantly biologic therapies, has
transformed the management of moderate and severe psoriasis in recent years. A novel oral …

Objectives To investigate the survival of apremilast in a cohort of psoriasis patients treated
with apremilast in a Greek hospital. Methods A retrospective cross-sectional study examined …

Introduction The broad and sustained efficacy of apremilast for psoriasis has been
demonstrated in randomized and real-world observational studies. Data from Central and …